Form 4: UTI CEO Grant Reports Stock Transactions
Insider Transaction Report
Universal Technical Institute CEO Jerome Alan Grant reported the acquisition of new restricted stock units and the sale of shares to cover tax obligations.
Summary
- Jerome Alan Grant, Chief Executive Officer and Director of Universal Technical Institute Inc (UTI), reported changes in his beneficial ownership of common stock.
- On December 11, 2025, Mr. Grant acquired 72,233 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock.
- These RSUs are scheduled to vest in three equal installments, beginning on December 15, 2026.
- On the same date, Mr. Grant disposed of a total of 111,720 shares of common stock at a price of $24.55 per share.
- These disposals were made to satisfy tax-withholding obligations upon the settlement and vesting of previously granted performance-based and regular restricted stock units from December 8, 2022, and December 8, 2023.
- Following these transactions, Mr. Grant's direct beneficial ownership of common stock stands at 499,531 shares.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions related to executive compensation, including the grant of new equity and the sale of shares for tax purposes. These are expected events and do not indicate a significant positive or negative shift in company fundamentals or outlook.
Positives
- The acquisition of 72,233 restricted stock units aligns management's interests with long-term shareholder value, as these units vest over time.
Negatives
- The disposal of 111,720 shares, while for tax-withholding purposes, represents a reduction in direct share ownership.
Future Outlook
The filing indicates future vesting of 72,233 restricted stock units, with the first installment beginning on December 15, 2026, suggesting a continued long-term incentive structure for the CEO.
Industry Context
This Form 4 filing details routine insider transactions, specifically the grant of equity compensation and subsequent tax-related share disposals. Such transactions are common across industries as part of executive compensation packages designed to align management incentives with shareholder interests.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as a component of executive compensation is a standard practice across many publicly traded companies, aligning with common industry benchmarks for long-term incentive plans.
- The withholding of shares to cover tax obligations upon vesting of equity awards is also a standard and widely accepted mechanism for managing tax liabilities associated with such compensation.
Stakeholder Impact
- Shareholders: The grant of RSUs to the CEO reinforces alignment with long-term shareholder value, while the tax-related share disposals are a routine part of executive compensation and generally have minimal impact on overall share float.
- Management: The CEO's compensation structure continues to include significant equity components, incentivizing performance over the long term.
Next Steps
- The 72,233 restricted stock units acquired on December 11, 2025, will begin vesting in three equal installments starting on December 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 12/08/2022 | Grant date for performance-based and regular restricted stock units, some of which vested on 12/11/2025. |
| 12/08/2023 | Grant date for restricted stock units, some of which vested on 12/11/2025. |
| 12/11/2025 | Date of acquisition of new restricted stock units and disposal of shares for tax withholding. |
| 12/12/2025 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing. |
| 12/15/2026 | Start date for the vesting of the 72,233 restricted stock units acquired on 12/11/2025. |
Recommendation
holdThis Form 4 filing details routine insider transactions, specifically the grant of restricted stock units and the sale of shares to cover tax obligations. These are expected events under an executive compensation plan and do not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a catalyst for significant price movement.
Keywords
UTI, Universal Technical Institute, Form 4, Insider Transaction, Restricted Stock Units, CEO, Stock Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.